Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Sanofi Stunned As FDA Says No To CAD Drug Sutimlimab
Deficiencies At Third-Party Manufacturing Facility
Nov 16 2020
•
By
Kevin Grogan
Dark day for Sanofi's sutimlimab • Source: Shutterstock
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from New Products
More from Scrip